Green tea leaf powder prevents dyslipidemia in high-fat diet-fed mice by modulating gut microbiota
Background: In the past, most researchers paid more attention to the biological activity of tea infusion and tea polyphenols; however, the prebiotic role of tea leaf powder is still unknown. Green tea leaf powder is rich in dietary fiber and is suggested to be beneficial for human health. Only limited studies have looked at the effects of tea leaf powder (which mainly contains tea dietary fiber) on gut microbiota and health.
Objective: The purpose of our study was to determine the effects of green tea leaf powder in preventing hyperlipidemia and to understand its potential lipid-lowering mechanism.
Design: Mice in three treatment groups were fed high-fat diets (HFDs) by administering either 0.5, 1.0, or 2.0 g/kg•d dietary fiber-enriched green tea leaf powder of low, medium, or high, respectively, for 12 weeks. Serum biochemical analyses and mRNA gene expression levels of related energy and lipid metabolism biomarkers from the liver were investigated. In addition, 16S rRNA cecal microbiota and fecal short chain fatty acids (SCFAs) were tested.
Results: Green tea leaf powder reduced body weight and total cholesterol of HFD-fed mice in a dose-dependent manner. Green tea leaf powder also increased satiety hormone secretion and reduced systemic inflammation of HFD-fed mice. Real-time polymerase chain reaction (PCR) analyses reconfirmed that green tea leaf powder prevented dyslipidemia by enhancing hepatic mRNA expression levels of peroxisome proliferator-activated receptor alpha, cholesterol 7a-hydroxylase, and Adenosine triphosphate (ATP)-binding cassette transporter A1 and decreasing the expression of fatty acid synthase, sterol regulatory element-binding protein 1c, and liver X receptor. Green tea leaf powder promoted the growth of Blautia, Oscillibacter, Ruminiclostridium, Alloprevotella, and Butyrivibrio and inhibited the growth of Erysipelatoclostridium, Desulfovibrio, and Candidatus_Saccharimonas in the cecum of HFD-fed mice.
Conclusion: In summary, our results indicate that green tea leaf powder improves lipid metabolism of HFDfed mice in a dose-dependent manner. The potential mechanism involves a synergistic role in reprogramming gut microbiota, increasing satiety hormone secretion, and reducing systemic inflammation.
- Kaczmarczyk MM, Miller MJ, Freund GG. The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer. Metabolism 2012; 61: 1058–66. doi: 10.1016/j.metabol.2012.01.017.
- Dahl WJ, Stewart ML. Position of the academy of nutrition and dietetics: health implications of dietary fiber. J Acad Nutr and Diet 2015; 115: 1861–70. doi: 10.1016/j.jand.2015.09.003.
- Hamaker BR, Tuncil YE. A perspective on the complexity of dietary fiber structures and their potential effect on the gut microbiota. J Mol Biol 2014; 426: 3838–50. doi: 10.1016/j.jmb.2014.07.028.
- Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 2016; 165: 1332–45. doi: 10.1016/j.cell.2016.05.041.
- Guo W, Shu Y, Yang X. Tea dietary fiber improves serum and hepatic lipid profiles in mice fed a high cholesterol diet. Plant Food Hum Nutr 2016; 71: 145–50. doi: 10.1007/s11130-016-0536-7.
- Axling U, Olsson C, Jie X, Fernandez C, Larsson S, Strom K, et al. Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice. Nutr Metab 2012; 9: 105. doi: 10.1186/1743-7075-9-105.
- Lan G, Chen H, Chen S, Tian J. Chemical composition and physicochemical properties of dietary fiber from Polygonatum odoratum as affected by different processing methods. Food Res Int 2012; 49: 406–10. doi: 10.1016/j.foodres.2012.07.047.
- Ferreira DS, Poppi RJ, Lima Pallone JA. Evaluation of dietary fiber of brazilian soybean (Glycine max) using near-infrared spectroscopy and chemometrics. J Cereal Sci 2015; 64: 43–7. doi: 10.1016/j/jcs.2015.04.004.
- Nakajima A, Nakatani A, Hasegawa S, Irie J, Ozawa K, Tsujimoto G, et al. The short chain fatty acid receptor GPR43 regulates inflammatory signals in adipose tissue M2-type macrophages. PLoS One 2017; 12: e0179696. doi: 10.1371/journal.pone.0179696.
- Kaplan RJ, Greenwood CE. Influence of dietary carbohydrates and glycaemic response on subjective appetite and food intake in healthy elderly persons. Int J Food Sci Nutr 2002; 53: 305–16. doi: 10.1080/09637480220138160.
- Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012; 61: 364–71. doi: 10.2337/db11-1019.
- Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G proteincoupled receptor, Gpr41. PNAS 2008; 105: 16767–72. doi: 10.1073/pnas.0808567105.
- Al-Muzafar HM, Amin KA. Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers. BMC Complem Altern M 2017; 17: 43. doi: 10.1186/s12906-016-1540-z.
- Yanai H, Yoshida H. Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives. Int J Mol Sci 2019; 20: 1190. doi: 10.3390/ijms20051190.
- Chassaing B, Gewirtz AT. Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicol Pathol 2014; 42: 49–53. doi: 10.1177/0192623313508481.
- Sanchez-Tapia M, Aguilar-Lopez M, Perez-Cruz C, Pichardo-Ontiveros E, Wang M, Donovan SM, et al. Nopal (Opuntia ficus indica) protects from metabolic endotoxemia by modifying gut microbiota in obese rats fed high fat/sucrose diet. Sci Rep 2017; 7: 4716. doi: 10.1038/s41598-017-05096-4.
- Xia X, Li G, Song J, Zheng J, Kan J. Hypocholesterolaemic effect of whole-grain highland hull-less barley fed a high-fat diet. Brit J Nutr 2018; 119: 1102–10. doi: 10.1017/s0007114518000831.
- Li T, Owsley E, Matozel M, Hsu P, Novak CM, Chiang JYL. Transgenic expression of cholesterol 7 alpha-hydroxylase in the liver prevents high-fat diet induced obesity and insulin resistance in mice. Hepatology 2010; 52: 678–90. doi: 10.1002/hep.23721.
- Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. PNAS 2013; 110: 9066–71. doi: 10.1073/pnas.1219451110.
- Li T, Gao J, Du M, Mao X. Milk fat globule membrane supplementation modulates the gut microbiota and attenuates metabolic endotoxemia in high-fat diet-fed mice. J Funct Foods 2018; 47: 56–65. doi: 10.1016/j.jff.2018.05.038.
- Kaakoush NO. Insights into the role of Erysipelotrichaceae in the human host. Front Cell Infect Microbiol 2015; 5: 84. doi: 10.3389/fcimb.2015.00084.
- Xiao S, Fei N, Pang X, Shen J, Wang L, Zhang B, et al. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. Fems Microbiol Ecol 2014; 87: 357–67. doi: 10.1111/1574-6941.12228.
- Zhai S, Zhu L, Qin S, Li L. Effect of lactulose intervention on gut microbiota and short chain fatty acid composition of C57BL/6J mice. Microbiologyopen 2018; 7: e00612. doi: 10.1002/mbo3.612.
- Tong X, Xu J, Lian F, Yu X, Zhao Y, Xu L, et al. Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional Chinese herbal formula: a multicenter, randomized, open label clinical trial. mBio 2018; 9: e02392–17. doi: 10.1128/mBio.02392-17.
- Kim BS, Song MY, Kim H. The anti-obesity effect of Ephedra sinica through modulation of gut microbiota in obese korean women. J Ethnopharmacol 2014; 152: 532–539. doi: 10.1016/j.jep.2014.01.038.
- Yoav S, Barak Y, Shamshoum M, Borovok I, Lamed R, Dassa B, et al. How does cellulosome composition influence deconstruction of lignocellulosic substrates in Clostridium (Ruminiclostridium) thermocellum DSM 1313? Biotechnol Biofuels 2017; 10: 222. doi: 10.1186/s13068-017-0909-7.
- Shang Q, Song G, Zhang M, Shi J, Xu C, Hao J, et al. Dietary fucoidan improves metabolic syndrome in association with increased Akkermansia population in the gut microbiota of high-fat diet-fed mice. J Funct Foods 2017; 28: 138–46. doi: 10.1016/j/jff.2016.11.002.
- Damms-Machado A, Mitra S, Schollenberger AE, Kramer KM, Meile T, Koenigsrainer A, et al. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int 2015; 2015: 806248. doi: 10.1155/2015/806248.
- Shao T, Shao L, Li H, Xie Z, He Z, Wen C. Combined signature of the fecal microbiome and metabolome in patients with gout. Front Microbiol 2017; 8: 268. doi: 10.3389/fmicb.2017.00268.
- Lin H, An Y, Hao F, Wang Y, Tang H. Correlations of fecal metabonomic and microbiomic changes induced by high-fat diet in the pre-obesity state. Sci Rep 2016; 6: 21618. doi: 10.1038/srep21618.
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International License
Authors retain copyright of their work, with first publication rights granted to SNF Swedish Nutrition Foundation.